The Allergy Outcome Survey (AOS) is a reliable measure used to monitor patients with allergic rhinitis. It was developed for and included in the Outcomes Measures of Immunotherapy in Allergic Rhinitis (OMIAR-1) project, designed to study the benefits of immunotherapy in the treatment of allergic rhinitis. Preliminary results indicate that AOS is specific, brief, reliable, and easy to use. Also, it is useful for evaluating change with therapy and can be used alone as a performance metric or in combination with other measures as part of a more complete outcomes monitoring system. As the OMIAR-1 study progresses, more information will be available on the advantages and limitations of the AOS.
Get full access to this article
View all access options for this article.
References
1.
NormanPS.A review of immunotherapy. Allergy1978; 33:62–70.
2.
PruzanskyJJPattersonR.Immunologic changes during hyposensitization therapy. JAMA1968; 203:805–6.
3.
GliklichREMetsonR.Techniques for outcomes research in chronic sinusitis. Laryngoscope1995; 105:387–90.
4.
GliklichREHilinskiJ.Longitudinal sensitivity of generic versus specific health instruments in chronic sinusitis. Qual Life Res1995; 4:27–32.
5.
WareJEJrSherbourneCD.The MOS 36-item Short-form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care1992; 30:473–83.
6.
McHorneyCAWareJEJrRackezAE.The MOS 36-item Short-form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care1993; 31:247–63.
7.
JuniperEFGuyattGH.Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy1991; 21:77–83.
